|
|
|
|
| LEADER |
00000cam a2200000 a 4500 |
| 001 |
EBSCO_on1204607283 |
| 003 |
OCoLC |
| 005 |
20231017213018.0 |
| 006 |
m o d |
| 007 |
cr ||||||||||| |
| 008 |
201111s2020 si o 000 0 eng d |
| 040 |
|
|
|a YDX
|b eng
|e pn
|c YDX
|d N$T
|d OCLCO
|d EBLCP
|d OCLCF
|d UKAHL
|d OCLCQ
|d OCLCO
|d OCLCQ
|d OCLCO
|
| 020 |
|
|
|a 9811482756
|q (electronic bk.)
|
| 020 |
|
|
|a 9789811482755
|q (electronic bk.)
|
| 029 |
1 |
|
|a AU@
|b 000071377520
|
| 035 |
|
|
|a (OCoLC)1204607283
|
| 050 |
|
4 |
|a QR188.6
|
| 082 |
0 |
4 |
|a 616.99/4079
|2 23
|
| 049 |
|
|
|a UAMI
|
| 245 |
0 |
0 |
|a PERSONALIZED IMMUNOTHERAPY FOR TUMOR DISEASES AND BEYOND /
|c editors, Biaoru Li, Alan Larson, Shen Li.
|
| 260 |
|
|
|a Singapore :
|b BENTHAM Science PUBLISHER,
|c 2020.
|
| 300 |
|
|
|a 1 online resource
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 505 |
0 |
|
|a Cover -- Title -- Copyright -- End User License Agreement -- Contents -- Preface -- REFERENCES -- List of Contributors -- INTRODUCTION -- MHC and Cancer Immunotherapy -- Li-Hua Jiang1,* and Wei-Hua Yan2 -- OVERVIEW OF MHC GENES AND MOLECULES -- 1. Characteristics of the HLA Gene Complex -- 2. HLA Molecule Structure -- 3. Distribution and Function of HLA Molecules -- 4. MHC Allele Detection -- MHC CLASS I MOLECULAR LOSS AND CANCER IMMUNOTHERAPY -- 1. Loss of Class I HLA Expression in Tumor Tissues -- 2. Types of Class I HLA Deletion.
|
| 505 |
8 |
|
|a 3. Expression of Class I HLA Molecules and Efficiency of Immunotherapy -- 4. The Relation Between Selective Pressure of Immunocyte and Changes of Class-I HLA Expression Pattern in Tumor Cells -- EXPRESSION LEVELS OF NONCLASSICAL MHC CLASS I AND TUMOR IMMUNE ESCAPE -- 1. The HLA Class I Antigen Expression and Cancer -- 2. Roles of HLA Ib Antigens in Immune Modulation -- 3. Clinical Relevance of HLA Ib Expression in Cancers -- 4. Prospective of HLA-E and HLA-G Targeted Cancer Immunotherapy -- MHC FOR T-CELL EPITOPE AND ACTIVE IMMUNE VACCINES -- MHC FOR ADOPTIVE IMMUNE CELL THERAPY -- CONCLUSION
|
| 505 |
8 |
|
|a CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Immune Cells Signaling-Pathway and Genomic Profiles for Personalized Immunotherapy -- Wei Zhang1, Yan Qu1, Meihua Lin1, Amit Datta1, George E. Liu1,2 and Biaoru Li1,3,* -- INTRODUCTION -- T-CELL MEMBRANE SIGNALING -- T-CELLS PATHWAY AND NETWORKS -- GENOMIC EXPRESSION PROFILE OF T-CELLS -- 1. Genomic Expression Profiles of TIL -- 2. Genomic Expression Profiles from Peripheral Blood Immune Cells -- GENOMIC EXPRESSION PROFILE OF B-CELL -- 1. Genomic Expression Profiles of B-Lymphocyte -- 2. Network of B-lymphocyte
|
| 505 |
8 |
|
|a GENOMIC EXPRESSION PROFILE AND NETWORK OF NK-CELL -- 1. NK-Lymphocyte -- 2. Genomic Expression Profiles of NK-Lymphocyte -- 3. Network of NK-Lymphocyte -- GENOMIC EXPRESSION PROFILE OF NKT-CELL -- 1. NKT-Lymphocyte -- 2. Genomic Expression Profiles and Network of NKT-Lymphocyte -- GENOMIC EXPRESSION PROFILE OF MACROPHAGE -- 1. Macrophage -- 2. Genomic Expression Profiles and Network of Macrophages -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Immunoassay of Personalized Immunotherapy -- Li-Hua Jiang1 and Biaoru Li1,2,* -- INTRODUCTION
|
| 505 |
8 |
|
|a BASIC RECORD OF IMMUNE FUNCTION AND RESPONSE -- Delayed-Type Hypersensitivity In Vivo -- Measures of Immune Function Ex Vivo -- 1. Detection of T-cell Number with Intracellular Cytokines by Flow Cytometry -- 2. Detection of Secreted Cytokines by ELISA Assays -- 3. Lymphoproliferation Assay -- 4. CTL and Quantifying CTL -- Measures of Antigen-Specific Immune Responses In Vitro/Ex Vivo -- 1. Peptide MHC Tetramers -- 2. TCR Complementarity Determining Region -- Measurement of Cytokine mRNA -- Measurement of Tumor Antibodies -- MEASUREMENT OF IMMUNE TARGETS FOR IMMUNOTHERAPY
|
| 590 |
|
|
|a eBooks on EBSCOhost
|b EBSCO eBook Subscription Academic Collection - Worldwide
|
| 650 |
|
0 |
|a Cancer
|x Immunological aspects.
|
| 650 |
|
0 |
|a Cancer
|x Immunotherapy.
|
| 650 |
|
0 |
|a Tumors
|x Immunological aspects.
|
| 650 |
|
6 |
|a Cancer
|x Immunologie.
|
| 650 |
|
6 |
|a Cancer
|x Immunothérapie.
|
| 650 |
|
6 |
|a Tumeurs
|x Immunologie.
|
| 650 |
|
7 |
|a Cancer
|x Immunological aspects
|2 fast
|
| 650 |
|
7 |
|a Cancer
|x Immunotherapy
|2 fast
|
| 650 |
|
7 |
|a Tumors
|x Immunological aspects
|2 fast
|
| 700 |
1 |
|
|a Li, Biaoru.
|
| 700 |
1 |
|
|a Larson, Alan.
|
| 700 |
1 |
|
|a Li, Shen.
|
| 856 |
4 |
0 |
|u https://ebsco.uam.elogim.com/login.aspx?direct=true&scope=site&db=nlebk&AN=2669216
|z Texto completo
|
| 938 |
|
|
|a Askews and Holts Library Services
|b ASKH
|n AH38209236
|
| 938 |
|
|
|a ProQuest Ebook Central
|b EBLB
|n EBL6424217
|
| 938 |
|
|
|a EBSCOhost
|b EBSC
|n 2669216
|
| 938 |
|
|
|a YBP Library Services
|b YANK
|n 301732159
|
| 994 |
|
|
|a 92
|b IZTAP
|
